Showing 1521-1530 of 10720 results for "".
- Ultrasound Detects Subclinical Joint and Nail Changes in Pediatric Psoriasishttps://practicaldermatology.com/news/ultrasound-detects-subclinical-joint-and-nail-changes-in-pediatric-psoriasis/2487206/Musculoskeletal ultrasound may help identify early inflammatory changes in children with psoriasis before the onset of clinically apparent arthritis, according to findings from a pilot study evaluating joint, entheseal, and nail abnormalities in pediatric patients.
- Ixekizumab Plus Tirzepatide Improves PASI and Weight Loss in Psoriasis Studyhttps://practicaldermatology.com/news/ixekizumab-plus-tirzepatide-improves-pasi-100-and-weight-loss-in-psoriasis-trial/2487181/New research published online in JAMA Dermatology found that combining ixekizumab with tirzepatide significantly improved both psoriasis clea
- Systematic Review Highlights Comparative Outcomes Across Molluscum Contagiosum Therapieshttps://practicaldermatology.com/news/systematic-review-highlights-comparative-outcomes-across-molluscum-contagiosum-therapies/2487169/A new systematic review evaluating treatments for molluscum contagiosum (MC) found that curettage, potassium hydroxide (KOH), autoinoculation, and podophyllotoxin demonstrated some of the highest lesion clearance rates among currently available therapies, while ne
- Study: Hair Care Regimen May Enhance Minoxidil Response in Women With Hair Losshttps://practicaldermatology.com/news/seen-study-suggests-hair-care-regimen-may-enhance-minoxidil-response-in-women-with-hair-loss/2487130/SEEN Hair Care presented new clinical findings at the 2026 Music City Symposium for Cosmetic Advances and Laser Education (SCALE), suggesting that a non-comedogenic, non-irritating hair care regimen may improve outcomes with topical minoxidil 5% foam in women with
- From SCALE 2026: Practical Strategies for Treating GLP-1–Related Aesthetic Changeshttps://practicaldermatology.com/news/from-scale-2026-practical-strategies-for-treating-glp-1related-aesthetic-changes/2487118/At the 2026 Music City SCALE meeting, Terrence Keaney, MD, discussed how dermatologists can proactively address facial aging, skin laxity, hair loss, and muscle loss associated with GLP-1–mediated weight reduction, outlining a practical framework for managing some of the aesthetic issues related
- From SCALE 2026: Microneedling Treatment Reduces Periorbital Wrinkle Severityhttps://practicaldermatology.com/news/microneedling-treatment-reduces-periorbital-wrinkle-severity/2487121/A prospective clinical study presented at the 2026 Music City SCALE Annual Meeting demonstrated significant improvement in periorbital wrinkles following treatment with the SkinStylus SteriLock MicroSystem (Hydrafacial LLC). The study evaluated the safety and effic
- From SCALE 2026: Dermatologists Navigate the Expanding Role of GLP-1s in Skin Health and Aesthetic Carehttps://practicaldermatology.com/news/dermatologists-navigate-the-expanding-role-of-glp-1s-in-skin-health-and-aesthetic-care/2487095/As use of GLP-1 receptor agonists continues to surge, dermatologists are increasingly encountering the downstream effects of these medications in both medical and cosmetic practice. During a session at the 2026 Music City SCALE meeting in Nashville, dermatologist and researcher Glynis Ablon, MD,
- Pharmacal Recalls MG217 Eczema Cream Lot Over Staph Contaminationhttps://practicaldermatology.com/news/pharmacal-recalls-mg217-eczema-cream-lot-over-staph-contamination/2487116/Pharmacal has issued a nationwide consumer-level recall of 1 lot of MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, 6-oz tube, after the product was found to be contaminated with Staphylococcus aureus, according to a company announcement pos
- Measure Up Data Support Long-Term Laboratory Safety With Upadacitinib in Atopic Dermatitishttps://practicaldermatology.com/news/measure-up-data-support-long-term-laboratory-safety-with-upadacitinib-in-atopic-dermatitis/2487114/Most laboratory parameters remained within normal limits through 140 weeks of upadacitinib treatment in adolescents and adults with moderate-to-severe atopic dermatitis (AD), according to findings presented at the 2026 Society for Investigative Dermatology Annual
- Global Skin Cancer Burden Projected to Rise Through 2050: Studyhttps://practicaldermatology.com/news/global-skin-cancer-burden-projected-to-rise-through-2050/2487086/A new research letter published online in JAMA Dermatology highlights widening global disparities in skin cancer burden and projects continued increases in melanoma, cutaneous squamous cell carcinoma (cSCC), and basal cell c